Solana Co — Director's Dealing 2017

Aug 11, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2017-08-04

Reporting Person: ANDREEFF DANE (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	1252649	Indirect
Class A Common Stock	274112	Indirect
Class A Common Stock	62132	Indirect
Class A Common Stock	651707	Indirect
Class A Common Stock	100000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant to Purchase Class A Common Stock	$1.18	2019-04-18	Class A Common Stock (284327)		Indirect
Warrant to Purchase Class A Common Stock	$1.18	2019-04-18	Class A Common Stock (65661)		Indirect
Warrant to Purchase Class A Common Stock	$1.18	2019-04-18	Class A Common Stock (22837)		Indirect
Warrant to Purchase Class A Common Stock	$1.18	2019-04-18	Class A Common Stock (160174)		Indirect

Footnotes

F1: The shares and warrants are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F2: The shares and warrants are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F3: The shares and warrants are held by Maple Leaf Offshore, Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, LLC, the investment manager of MLO and as such may be deemed to beneficially own the securities held by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F4: The shares and warrants are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F5: The warrants may be exercised at any time after the original issue date until the expiration date.

F6: Translated into U.S. dollars from Canadian dollars based on buying rate from Federal Reserve Bank of USD $1.0000= CAD $1.26675 on August 8, 2017, based on a warrant exercise price of CAD$1.50.